Bionano Genomics, Inc. (BNGO) financial statements and ratios from SEC XBRL: revenue $28.51M (TTM), net margin -92.6%, revenue growth -7.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $28.51M |
| Net Margin | -92.6% |
| Revenue Growth (YoY) | -7.4% |
| EPS Growth (YoY) | -94.5% |
| Price / Book | 0.45 |
| Price / Sales | 0.49 |
| Altman Z-Score | -14.16 (distress) |
| Sector P/E (Technology) | 33.9 |
BNGO overview · BNGO earnings · BNGO KPIs · BNGO investor relations · BNGO ownership · BNGO peers · BNGO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.